Invitris is a new team out of TU Munich funded to spin off a phage therapy biotech company based on their unique synthetic ph
Invitris is a new team out of TU Munich funded to spin off a phage therapy biotech company based on their unique synthetic phage production system. They're looking for an additional team member at the intersection of microbiology and the clinic.
Topics
| Published in | Capsid & Tail #84 |
|---|